ArticleHealth science reports2024

An overview of sulbactam-durlobactam approval and implications in advancing therapeutics for hospital-acquired and ventilator-associated pneumonia by

Ayush Anand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.